Sclerosis Treatment in Indore

Sclerosis Treatment in Indore

Scleroderma is a chronic autoimmune connective tissue condition affecting both skin and internal organs. It results from a defect in the immune system that causes too much collagen to be deposited in the tissues and damages small blood vessels.

While there is no cure for scleroderma, there are treatments to improve symptoms, prevent the condition from getting worse, and enhance your quality of life.

How you treat scleroderma is based upon the type of scleroderma you have (localized or systemic), how serious your condition is, and what areas of your body are affected. Common goals of treatment include helping reduce inflammation, keeping scar tissue from forming, improving blood flow, preventing organ damage, and relieving your symptoms.

If you have scleroderma that affects your skin, you may receive medications such as immunosuppressive drugs, including methotrexate, mycophenolate mofetil, or cyclophosphamide, to slow the progression of skin thickening and the progression of scleroderma. In addition to medication, you should also use moisturizing lotions and creams to help improve dry, tight, and itchy skin.

Those with vasospastic symptoms (Raynaud's Phenomenon) may be treated with vasodilators, including calcium channel blockers (e.g., Nifedipine), phosphodiesterase inhibitors, or prostacyclin analogs. It is also recommended to reduce exposure to the cold, quit smoking, and minimize stress to prevent vascular spasms.

If there are Internal Organ issues, we'll be using targeted treatments. Interstitial Lung Disease generally has Immuno-suppression and/or Anti-fibrotic and/or Ant-inflammatories as potential therapies. Pulmonary Arterial Hypertension is usually given special medications such as Endothelin Receptor Antagonists or Phosphodiesterase Inhibitors. Gastrointestinal issues are usually treated with proton pump inhibitors for acid reflux, prokinetic agents for motility issues, and nutritional supplementation for any lack of nutrition. Renal involvement, especially the first presentation of Scleroderma Renal Crisis (a medical emergency) is usually managed with Medicinal treatment via ACE Inhibitors.

Along with Medicine, supportive care has a very important role in patient management. In addition to regular monitoring, educational information for patients, annual vaccinations, and psychological support, supportive care is essential for the long-term care of patients with Systemic Sclerosis. The best way to help a patient with Systemic Sclerosis is to have an integrated multi-disciplinary approach; this would include rheumatologists, dermatologists, pulmonary doctor(s) and many more.

Conclusion:

Systemic sclerosis is a complex chronic autoimmune disease that requires long-term individualized treatment. There is no cure for systemic sclerosis at this time. However, with early diagnosis, targeted medical therapies, lifestyle changes, and an integrated multi-disciplinary approach, patients will be able to effectively manage their symptoms, reduce their risk of complications, and lengthen their survival. In most patients, with continual treatments and consistent monitoring, better disease control can lead to a better quality-of-life than would typically be achieved via Time and Disease progression.